Related Experiment Video
Updated: Mar 31, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
Caveolin-1 regulates cell apoptosis and invasion ability in paclitaxel-induced multidrug-resistant A549 lung cancer
Fei Han1, Long Zhang2, Yongxin Zhou3
1Department of Pathology, Shanghai Tongji Hospital Affiliated to Shanghai Tongji University Shanghai 200065, China ; Department of Pathology, Shanghai Chest Hospital Affiliated to Shanghai Jiao Tong University Shanghai 200030, China.
Abstract:
The aim of the study was to investigate the effect and potential mechanism of caveolin-1 (Cav1) knockdown in paclitaxel-resistant lung cancer A549/Taxol cells. The human paclitaxel-resistant lung cancer cell line A549/Taxol was transfected with a Cav1 shRNA lentiviral vector. Interference efficiency for Cav1 was detected by real-time PCR and Western blotting. A MTT assay was used to determine cell proliferation, and flow cytometry was used to detect the cell cycle stage and apoptosis. Cell migration and invasion capability were detected by a transwell assay. Protein levels of related signaling molecules were detected by Western blotting. We successfully constructed a stable A549/Taxol cell line expressing low levels of Cav1. Cav1 knockdown significantly inhibited cell proliferation and induced G0/G1 arrest and cell apoptosis in vitro and in vivo. In addition, these effects correlated significantly with a reduction in cyclin D1 expression and activation of the Bcl-2/Bax-mediated mitochondrial apoptosis pathway. Furthermore, knockdown of Cav1 inhibited cell migration and invasion, and this may be related to the inhibition of AKT and the subsequent decreased protein expression of MMP2, MMP7 and MMP9.
Insights
Knocking down caveolin-1 (Cav1) in paclitaxel-resistant lung cancer cells significantly inhibits proliferation and induces apoptosis. This mechanism involves regulating cyclin D1 and the Bcl-2/Bax pathway, impacting cell migration and invasion.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Paclitaxel resistance is a major challenge in lung cancer treatment.
- Caveolin-1 (Cav1) is implicated in cancer progression and drug resistance.
- Understanding Cav1's role in paclitaxel-resistant lung cancer is crucial for developing new therapies.
Purpose of the Study:
- To investigate the effect of caveolin-1 (Cav1) knockdown on paclitaxel-resistant lung cancer cells (A549/Taxol).
- To elucidate the underlying molecular mechanisms of Cav1's influence on drug resistance, proliferation, apoptosis, migration, and invasion.
Main Methods:
- Stable transfection of A549/Taxol cells with Cav1 shRNA lentiviral vector.
- Assessment of Cav1 knockdown efficiency using real-time PCR and Western blotting.
- Evaluation of cell proliferation (MTT assay), cell cycle and apoptosis (flow cytometry), and cell migration/invasion (Transwell assay).
- Analysis of related signaling molecules (e.g., cyclin D1, Bcl-2, Bax, AKT, MMPs) via Western blotting.
Main Results:
- Successful generation of a stable A549/Taxol cell line with reduced Cav1 expression.
- Cav1 knockdown significantly inhibited cell proliferation and induced G0/G1 cell cycle arrest.
- Cav1 knockdown promoted significant apoptosis, linked to the Bcl-2/Bax-mediated mitochondrial pathway.
- Reduced cyclin D1 expression was observed following Cav1 knockdown.
- Inhibition of cell migration and invasion was observed, potentially via AKT pathway inhibition and decreased MMP2, MMP7, and MMP9 expression.
Conclusions:
- Caveolin-1 (Cav1) knockdown is a promising strategy to overcome paclitaxel resistance in lung cancer.
- Cav1 plays a critical role in regulating proliferation, apoptosis, and metastasis in paclitaxel-resistant lung cancer cells.
- Targeting Cav1 may offer a therapeutic approach to enhance the efficacy of paclitaxel treatment for lung cancer.
Related Concept Videos
Drugs that Stabilize Microtubules
The Intrinsic Apoptotic Pathway
Intracellular Signaling Affects Focal Adhesions
Some...

